← Back to Search

Dietary Intervention

Dietary Interventions for Type 2 Diabetes (DG3D-Phase2 Trial)

N/A
Recruiting
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-65 years of age
Be able to attend all monitoring visits
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

DG3D-Phase2 Trial Summary

This trial will test whether different dietary patterns can impact risk factors for type 2 diabetes among African American adults.

Who is the study for?
This trial is for African American adults aged 18-65 living in Columbia, SC with a BMI of 25-49.9 kg/m2 who are not pregnant, breastfeeding, or planning pregnancy soon. Participants should not be on weight loss programs/medications or have had bariatric surgery and must be free from major health issues, eating disorders, drug/alcohol dependency, thyroid conditions, and diabetes.Check my eligibility
What is being tested?
The study tests three different diet patterns over one year to see their effects on healthy eating scores and risk factors for type 2 diabetes: U.S.-Style Eating Pattern, Mediterranean-Style Eating Pattern, and Vegetarian Eating Pattern. Participants will be randomly assigned to one of these diets.See study design
What are the potential side effects?
As this is a dietary intervention study focusing on healthy eating patterns rather than medication or surgical treatments, significant side effects are not expected. However, changes in diet may cause temporary digestive adjustments.

DG3D-Phase2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I can attend all required check-ups.
Select...
I am between 18 and 65 years old.

DG3D-Phase2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in HgbA1c
Changes in body weight
Changes in dietary quality
Secondary outcome measures
Changes in blood pressure

DG3D-Phase2 Trial Design

3Treatment groups
Experimental Treatment
Group I: Vegetarian dietExperimental Treatment1 Intervention
Participants in this group will be assigned to follow the Vegetarian dietary pattern as presented by the US Dietary Guidelines. As described here https://www.nia.nih.gov/health/usda-food-patterns: This eating pattern contains no meat, poultry, or seafood. Compared with the Healthy U.S.-Style Eating Pattern, it contains more soy products, eggs, beans and peas, nuts and seeds, and whole grains.
Group II: US Healthy DietExperimental Treatment1 Intervention
Participants in this group will be assigned to follow the Healthy US dietary pattern as presented by the US Dietary Guidelines. As described here https://www.nia.nih.gov/health/usda-food-patterns: This eating pattern is based on the types and amounts of foods Americans typically consume. The main types of food in this eating pattern include a variety of vegetables; fruits; whole grains; fat-free or low-fat dairy; seafood, poultry, meat, and eggs; and nuts, seeds, and soy products.
Group III: Mediterranean dietExperimental Treatment1 Intervention
Participants in this group will be assigned to follow the Mediterranean dietary pattern as presented by the US Dietary Guidelines. As described here https://www.nia.nih.gov/health/usda-food-patterns: This eating pattern contains more fruits and seafood and less dairy than the Healthy U.S.-Style Eating Pattern.

Find a Location

Who is running the clinical trial?

University of South CarolinaLead Sponsor
210 Previous Clinical Trials
120,231 Total Patients Enrolled
30 Trials studying Obesity
8,477 Patients Enrolled for Obesity

Media Library

Healthy Mediterranean-Style Eating Pattern (Dietary Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05254496 — N/A
Obesity Research Study Groups: Mediterranean diet, Vegetarian diet, US Healthy Diet
Obesity Clinical Trial 2023: Healthy Mediterranean-Style Eating Pattern Highlights & Side Effects. Trial Name: NCT05254496 — N/A
Healthy Mediterranean-Style Eating Pattern (Dietary Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05254496 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruits still eligible for enrollment in this investigation?

"According to records on clinicaltrials.gov, this medical trial is not currently enrolling participants, though it was initially posted on April 4th 2022 and recently updated May 4th of the same year. Despite its current inactivity there are 1686 other trials actively recruiting patients right now."

Answered by AI

What are the parameters for eligibility in this research endeavor?

"This medical study is seeking 198 individuals aged 18 to 65 with type 2 diabetes mellitus who live in the Columbia, SC area. Additionally, participants must meet additional criteria such as BMI between 25- 49.9 kg/m2 and self-identification as African American; furthermore, they should have no major health or psychiatric conditions, be free from drug or alcohol abuse, thyroid issues or pregnancy, and attend all monitoring visits willingly."

Answered by AI

Is the study open to applicants of a certain age bracket, such as those under 60 years old?

"The desired demographic for this clinical trial are individuals between 18 and 65 years old."

Answered by AI

Who else is applying?

What site did they apply to?
University of South Carolina
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

Why did patients apply to this trial?

I have tried several medications with unsuccessful results. I am hoping this will benefit me better.
PatientReceived 2+ prior treatments
~78 spots leftby Jun 2025